Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 HIV Infections 1 GIST 1 Cervical Cancer Screening 1 Breast Neoplasms 1

Interventions

Etoposide 79 Carboplatin 67 Cisplatin 58 durvalumab 29 Irinotecan 29 Radiotherapy 27 atezolizumab 23 Topotecan 21 anlotinib 19 Nivolumab 15 Drug Therapy 15 Radiosurgery 14 Gemcitabine 13 apatinib 12 Paclitaxel 12 toripalimab 10 Platinum 10 Docetaxel 10 tislelizumab 9 Temozolomide 9 PM 01183 8 pembrolizumab 7 olaparib 7 Magnetic Resonance Spectroscopy 7 Ipilimumab 7 Bevacizumab 7 Albumin-Bound Paclitaxel 7 irinotecan sucrosofate 6 Counseling 6 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Carcinoma × Coal Tar × Clear all

NCT01574300 2020-01-10

CASTLE

Addario Lung Cancer Medical Institute

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡